Sonia Singh1, Huiying Sun, Aslam H Anis. 1. Department of Healthcare and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
OBJECTIVE: Hip fracture is a common complication of osteoporosis, resulting in significant morbidity and mortality, with a high financial cost to the healthcare system. Hip protectors have been advocated as an effective method to prevent hip fractures in high-risk individuals. This study models the cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. METHODS: An incremental cost-effectiveness analysis was performed comparing hip protectors to "no treatment" and to "calcium and vitamin D supplements." The study population was a hypothetical cohort of 1000 nursing home residents. A societal perspective, with a lifetime time horizon, was adopted. Data regarding costs, effectiveness, and quality of life measures were collected from the current literature and from Peace Arch Hospital, a community hospital in White Rock, British Columbia, Canada. Sensitivity analysis was performed. RESULTS: Hip protector use was found to be a dominant strategy compared to no treatment and to calcium and vitamin D supplements. Dominance implies lower cost and higher effect, generating cost-effectiveness ratios less than zero. Dominance with respect to cost and effectiveness of hip protectors in preventing hip fractures persisted when the model was subjected to probabilistic sensitivity analysis. CONCLUSION: Cost-effectiveness analysis suggests that hip protectors could save money while preventing hip fractures and improving quality of life in nursing home residents.
OBJECTIVE:Hip fracture is a common complication of osteoporosis, resulting in significant morbidity and mortality, with a high financial cost to the healthcare system. Hip protectors have been advocated as an effective method to prevent hip fractures in high-risk individuals. This study models the cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. METHODS: An incremental cost-effectiveness analysis was performed comparing hip protectors to "no treatment" and to "calcium and vitamin D supplements." The study population was a hypothetical cohort of 1000 nursing home residents. A societal perspective, with a lifetime time horizon, was adopted. Data regarding costs, effectiveness, and quality of life measures were collected from the current literature and from Peace Arch Hospital, a community hospital in White Rock, British Columbia, Canada. Sensitivity analysis was performed. RESULTS: Hip protector use was found to be a dominant strategy compared to no treatment and to calcium and vitamin D supplements. Dominance implies lower cost and higher effect, generating cost-effectiveness ratios less than zero. Dominance with respect to cost and effectiveness of hip protectors in preventing hip fractures persisted when the model was subjected to probabilistic sensitivity analysis. CONCLUSION: Cost-effectiveness analysis suggests that hip protectors could save money while preventing hip fractures and improving quality of life in nursing home residents.
Authors: Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak Journal: Endocr Pract Date: 2010 Nov-Dec Impact factor: 3.443
Authors: Anna M Sawka; Nofisat Ismaila; Parminder Raina; Lehana Thabane; Sharon Straus; Jonathan D Adachi; Amiram Gafni; Alexandra Papaioannou Journal: Can Fam Physician Date: 2010-11 Impact factor: 3.275
Authors: Anna M Sawka; Madeline Nixon; Lora Giangregorio; Lehana Thabane; Jonathan D Adachi; Amiram Gafni; Ron Goeree; Parminder Raina; Jennifer Ranford; Alexandra Papaioannou Journal: J Am Med Dir Assoc Date: 2007-04-18 Impact factor: 4.669
Authors: Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak Journal: Endocr Pract Date: 2010 Nov-Dec Impact factor: 3.443
Authors: Anna M Sawka; Nofisat Ismaila; Ann Cranney; Lehana Thabane; Monika Kastner; Amiram Gafni; Linda J Woodhouse; Richard Crilly; Angela M Cheung; Jonathan D Adachi; Robert G Josse; Alexandra Papaioannou Journal: PLoS One Date: 2010-03-03 Impact factor: 3.240
Authors: Jiří Skála-Rosenbaum; Valér Džupa; Radek Bartoška; Daniel Říha; Petr Waldauf; Václav Báča Journal: Int Orthop Date: 2015-01-08 Impact factor: 3.075